These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3509523)

  • 21. Morphological changes in the hearts of CD1 mice following chronic treatment with doxorubicin and lonidamine.
    Sanguedolce R; Flandina C; Cucchiara T; Varvara F; Rausa L
    Res Commun Chem Pathol Pharmacol; 1993 Oct; 82(1):81-9. PubMed ID: 8272575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relation between electrocardiographic changes and morphologic changes induced by anthracyclines].
    Villani F; Favalli L; Lanza E; Poggi P
    Cardiologia; 1987 Jun; 32(6):585-90. PubMed ID: 3621270
    [No Abstract]   [Full Text] [Related]  

  • 23. Anthracycline metabolism and toxicity in human myocardium: comparisons between doxorubicin, epirubicin, and a novel disaccharide analogue with a reduced level of formation and [4Fe-4S] reactivity of its secondary alcohol metabolite.
    Minotti G; Licata S; Saponiero A; Menna P; Calafiore AM; Di Giammarco G; Liberi G; Animati F; Cipollone A; Manzini S; Maggi CA
    Chem Res Toxicol; 2000 Dec; 13(12):1336-41. PubMed ID: 11123976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of Doxorubicin cardiotoxicity by iron loading in a rodent model.
    Panjrath GS; Patel V; Valdiviezo CI; Narula N; Narula J; Jain D
    J Am Coll Cardiol; 2007 Jun; 49(25):2457-64. PubMed ID: 17599610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of doxorubicin and 4'-epi-doxorubicin on lipid peroxidation in mouse heart, lungs and liver. Part II.
    Pierściński G; Drzewoski J; Nowak D
    Pol J Pharmacol; 1994; 46(1-2):55-9. PubMed ID: 7981772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety assessment of new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. II. Histologic and ultrastructural pathology.
    Sparano BM; Gordon G; Hall C; Iatropoulos MJ; Noble JF
    Cancer Treat Rep; 1982 May; 66(5):1145-58. PubMed ID: 7083217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice.
    Naidu MU; Kumar KV; Mohan IK; Sundaram C; Singh S
    Indian J Exp Biol; 2002 Aug; 40(8):894-900. PubMed ID: 12597018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs: possible relationship to cardiotoxicity.
    Lehotay DC; Levey BA; Rogerson BJ; Levey GS
    Cancer Treat Rep; 1982 Feb; 66(2):311-6. PubMed ID: 6120040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary evaluation of myocardial toxicity of 4'-deoxydoxorubicin: experimental and clinical results.
    Villani F; Comazzi R; Genitoni V; Lacaita G; Guindani A; Crippa F; Monti E; Piccinini F; Rozza A; Lanza E
    Drugs Exp Clin Res; 1985; 11(3):223-31. PubMed ID: 3836127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
    Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
    J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.
    Arola OJ; Saraste A; Pulkki K; Kallajoki M; Parvinen M; Voipio-Pulkki LM
    Cancer Res; 2000 Apr; 60(7):1789-92. PubMed ID: 10766158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A functional assessment of the relative cardiotoxicity of adriamycin and epirubicin in the rat.
    Yeung TK; Simmonds RH; Hopewell JW
    Radiother Oncol; 1989 Jul; 15(3):275-84. PubMed ID: 2772255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free radical-dependent DNA lesions are involved in the delayed cardiotoxicity induced by adriamycin in the rat.
    Monti E; Prosperi E; Supino R; Bottiroli G
    Anticancer Res; 1995; 15(1):193-7. PubMed ID: 7733633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity.
    Kleiner Y; Bar-Am O; Amit T; Berdichevski A; Liani E; Maor G; Reiter I; Youdim MB; Binah O
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):268-77. PubMed ID: 18806608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of anthracycline antibiotics on oxygen radical formation in rat heart.
    Doroshow JH
    Cancer Res; 1983 Feb; 43(2):460-72. PubMed ID: 6293697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of verapamil on doxorubicin cardiotoxicity: altered muscle gene expression in cultured neonatal rat cardiomyocytes.
    Akimoto H; Bruno NA; Slate DL; Billingham ME; Torti SV; Torti FM
    Cancer Res; 1993 Oct; 53(19):4658-64. PubMed ID: 8402643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin-induced late cardiotoxicity: delayed impairment of Ca2+-handling mechanisms in the sarcoplasmic reticulum in the rat.
    Chugun A; Temma K; Oyamada T; Suzuki N; Kamiya Y; Hara Y; Sasaki T; Kondo H; Akera T
    Can J Physiol Pharmacol; 2000 Apr; 78(4):329-38. PubMed ID: 10772060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress.
    Li W; Xu B; Xu J; Wu XL
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer.
    Injac R; Perse M; Cerne M; Potocnik N; Radic N; Govedarica B; Djordjevic A; Cerar A; Strukelj B
    Biomaterials; 2009 Feb; 30(6):1184-96. PubMed ID: 19046599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of rat and human cardiac guanylate cyclase by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity.
    Levey GS; Levey BA; Ruiz E; Lehotay DC
    Trans Assoc Am Physicians; 1979; 92():303-8. PubMed ID: 44927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.